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SUMMARY 
We have investigated the influence of anti-rabies vaccination on the onset of the 
disease as well as the delay of death in foxes previously infected with rabies virus. A live 
vaccinia recombinant virus expressing the rabies virus glycoprotein (VVTGgRAB) 
was used as vaccine. Foxes were divided into six experimental groups of four animals. 
On day 0, each fox was experimentally infected with a rabies virus suspension. 
VVTGgRAB was administered by the oral route to each animal of three groups on day 
0, 3 or 14. Foxes of other groups were used as unvaccinated controls or received, on day 
0, the parental Copenhagen strain of vaccinia virus. The length of post-challenge 
survival and duration of clinical disease were recorded for each animal tested. All 
foxes, vaccinated or not, died from rabies as confirmed by fluorescent antibody tests. 
Animals vaccinated on days 0 and 3 died after a shorter period of incubation than 
unvaccinated controls. On the other hand, animals vaccinated on day 14 post-challenge 
died later than control animals. Foxes administered vaccinia virus died at the same 
time as unvaccinated controls. These results demonstrate that e rly and late death 
phenomena, as consequences of interactions between oral vaccination with 
VVTGgRAB and rabies infection, can occur in foxes. 
Attempts to control rabies by vaccinating wild carnivores with attenuated strains of rabies 
virus seem promising (Steck et al., 1982; Schneider & Cox, 1983; Pastoret et al., 1987; Brochier 
et al., 1988a). However, the use of conventional vaccines remains controversial s far as their 
innocuity and heat stability are concerned. In order to improve both the safety and stability of 
the vaccine used in the field, a recombinant vaccinia virus (VV) expressing the immunizing 
glycoprotein of rabies virus (VVTGgRAB) has been developed (Kieny et al., 1984). The 
potential of this recombinant vaccinia-rabies virus to protect foxes (Vulpes vulpes) (adult and 
young), raccoons (Procyon lotor) and striped skunks (Mephitis mephitis) against rabies has 
already been demonstrated. Oral, intradermal and subcutaneous administrations of 
VVTGgRAB to those target species elicit high levels of rabies virus-neutralizing antibodies and 
long-term protection against rabies (Blancou et al., 1986; Rupprecht et al., 1986; Tolson et al., 
1987; Brochier et al., 1988 b). VVTGgRAB oral administration was shown to be innocuous for 
target species (foxes, raccoons, striped skunks) as well as non-target animals (four laboratory, 
four domestic and 13 wild European species) (Wiktor et al., 1985; Blancou et al., 1986, 1988; 
Rupprecht et al., 1986; Tolson et aL, 1987; Brochier et al., 1988c; B. Brochier, unpublished 
results). Furthermore, as far as safety is concerned, the absence of horizontal transmission of 
VVTGgRAB has been confirmed in foxes, badgers (Meles meles), wild boars (Sus scrofa), cattle, 
dogs and ferrets (Putorius furo) (Brochier et al., 1988c). 
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It is also of major importance to preclude some epizootic risks such as the emergence of 
asymptomatic carriers of rabies virus. This situation could occur in the field by vaccinating 
naturally infected animals during the incubation period. Among interactions between 
vaccination and infection, the early death phenomenon (i.e. reduction of the incubation period 
in an animal vaccinated after infection) has been experimentally observed in monkeys and mice 
(Sikes et al., 1971 ;Blancou et al., 1980; Bijlenga et al., 1988). It appears that early death may also 
occur in humans who have been treated with vaccine, with or without accompanying serum 
therapy, after exposure to rabies virus. The humoral immune response (neutralizing antibodies) 
seems to play a role in the early death phenomenon (Blancou et al., 1979b; Andral et al., 1981 ;
Prabhakar & Nathanson, 1981). 
In a previous experiment on fox vaccination against rabies with an inactivated vaccine, an 
early death phenomenon was suspected but could not be demonstrated since several parameters 
(time interval between infection and vaccination, time of vaccination, route and dose of 
inoculation, site of biting, etc.) were not controlled (Thiriart et al., 1985). The purpose of this 
study was to investigate in foxes the interaction between experimental rabies infection and post- 
exposure vaccination with VVTGgRAB. 
Twenty-four adult foxes trapped in the wild were raised in the experimental centre of Atton 
(Nancy, France). After capture, they were sexed, marked, treated against parasites and 
vaccinated against distemper, Rubarth's disease and leptospirosis as previously described 
(Dubreuil et al., 1979). They were shown to be serologically negative for rabies virus before being 
included in the study. In the first trial, 16 foxes were divided into four experimental groups of 
four animals (groups A, B, C and D). On day 0, each of them was challenged by inoculation in 
the right temporal muscle with 1 ml of a rabies virus suspension containing 103.6 mouse 
intracerebral (i.c.) LDso. This virus challenge suspension consisted of a homogenate ofsalivary 
glands of foxes that had died from natural rabies (strain GS 7) (Blancou et al., 1979a). A 
suspension of 108 TCIDso of live modified vaccinia (Copenhagen strain) rabies glycoprotein 
(ERA strain) recombinant virus (VVTGgRAB-26D3 187XP strain) was orally administered to
each animal of groups A, B and C on day 0, 3 or 14 respectively. Foxes of group D were used as 
unvaccinated controls. 
In the second trial, eight foxes were divided into two experimental groups of four animals 
(groups E and F). On day 0, each fox was challenged by inoculation in the right temporal muscle 
with 1 ml of the viru s suspension containing 10 z'8 mouse i.c. LD50. On day 0, 107.3 TCID5o of 
the parental Copenhagen strain of VV was administered by the oral route to each animal of 
group E; foxes of group F were used as uninoculated controls. In both trials, VVTGgRAB and 
VV were administered by direct application into the mouth via a needle-less yringe (vol. 1 ml). 
The duration of clinical disease and the day of death post-challenge were recorded for each 
animal tested. Since the delays of death do not follow a Gaussian distribution (Blancou et aL, 
1979b), these data were analysed according to the non-parametric Mann-Whitney test. The 
results were compared according to the one-failed-critical values given by Zar (1974). All foxes 
succumbed to rabies virus challenge. Rabies was confirmed by the analytical techniques 
recommended by the World Health Organization: fluorescent antibody tests and i.c. inoculation 
of mice (Koprowski, 1973). 
Table 1 gives the length of post-challenge survival and duration of clinical disease of each fox 
included in trial no. 1. The delays of death of groups A and B, taken as a whole, were statistically 
shorter (mean values 17.25 days) than that of unvaccinated control foxes (group D) (mean value 
19-25 days). The significance l vel was 5 ~. Although animals of group C died later (mean value 
22.25 days) than those of group D, the significance l vel of this difference was only 10 %. Table 1 
also gives the length of post-challenge survival and duration of clinical disease of each fox 
included in trial no. 2. Animals of groups E and F, challenged with 102.8 LDs0 (mouse i.c.), 
similarly died on days 17 to 19 post-challenge (mean values 18.25 days). As shown in Table 1, no 
difference in the duration and pattern of clinical disease could be observed between the six 
experimental groups (mean values 2-75 days in groups A, B, C and D; 1 and 1.25 days in groups 
E and F respectively). 
These results demonstrate hat the early death phenomenon, asa consequence of interaction 
Downloaded from www.microbiologyresearch.org by
IP:  139.165.88.155
On: Tue, 14 May 2019 15:01:45
Short communication 1603 
Table 1. Effect of oral inoculation of foxes with VVTGgRAB (groups A, B and C) or VV 
(group E) on the same day or several days after rabies challenge 
Duration of 
Rabies challenge Day of Day of death clinical disease 
Trial Group Fox no. (mouse i.c. LDso; day 0) vaccination post-challenge (days) 
1 A 655 103.6 0 15 "1 3 ] 
656 0 17 L -~-~-17.25 2 ) .~= 2.75 
657 0 18 r 2 
658 0 19 .J 4 
/ 
B 664 103.6 3 15 "1 2 "] 
665 3 17 ~ 4 = 17.25 ~ = 2.75 666 3 18 3 
667 3 19 .J 2 
C 168 103.6 14 20 I~  2)  
169 14 2 = 22.25 3 170 14 3 2 --- 2-75 
171 14 24 .J 3 
D 162 103.6 Unvaccinated i i~  2~ 
163 controls ~ = 19.25 2 
177 2 ~--- 2.75 
178 20 J 5 
2 E TVP1 102.8 0 19 "~ - 1~ 
TVP2 0 19 2 
TVP3 0 18 f ~= 18.25 0 ~=1 
TVP4 0 17 .J 1 
F 700 102.8 Unvaccinated 19 "1 1 "1 
718 controls 19 ~ ~ = 18.25 2 ~ X = 1-25 
720 18 1 
777 17 1 
between vaccination and rabies infection, can occur in foxes as well as in mice and monkeys as 
previously demonstrated by other workers. It may explain the previous observations of early 
death occurring in naturally infected foxes vaccinated by the parenteral route with an 
inactivated vaccine (Thiriart et al., 1985). Moreover, a late death phenomenon as previously 
observed in mice (Bijlenga et al., 1988) appears in foxes when vaccinated a few days before 
clinical disease. Such variations in the incubation period may occur in the field during fox 
vaccination campaigns. 
The absence of protection is observed in all foxes included in this study. Both death 
phenomena re thus likely to impede the emergence of survivors Of rabies infection and 
subsequently lead to asymptomatic carriers of rabies virus. Therefore, there do not seem to be 
peculiar epidemiological risks in similar natural conditions. Nevertheless, other effects could 
occur when vaccinating at other time intervals after or before natural infection. In this regard, 
field conditions need to be considered: foxes are liable to ingest one or several vaccine doses at 
different imes before or after natural contamination; furthermore, the time intervals between 
successive ingestions can vary widely. Post-exposure protection with two successive 
intramuscular dministrations of VVTGgRAB has already been conferred to hamsters (Wiktor 
et al., 1985). It could be suggested that curative vaccination of foxes incubating rabies would be a 
possible event in the wild. Further investigations including other time intervals between 
vaccination and natural infection need to be done. 
It is also interesting to note that the rabies virus glycoprotein (the only rabies virus component 
of VVTGgRAB) administered by the oral route can induce the early death phenomenon. This 
effect could not be induced in animals inoculated with the parental strain of VV. It does not 
mean that the other rabies virus antigens do not participate in the phenomenon, but rather the 
glycoprotein may account for the effect. This result confirms that the early death reaction to 
vaccine in post-exposure treatment is likely to be caused by neutralizing antibodies (induced by 
the glycoprotein) as has been demonstrated in other animal species (Blancou et al., 1979b). 
Previous studies have also demonstrated that neutralizing antibodies and interferon are 
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involved in the post-exposure protect ion.  The immune response induced by oral  admin is t ra t ion  
of VVTGgRAB (i.e. k inet ics and  levels of in ter feron and  neutra l iz ing ant ibodies)  needs to be 
evaluated and  compared  to the response induced by a t tenuated  stra ins of  rabies virus. 
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